Altered platelet monoamine oxidase-B activity in idiopathic parkinson's disease

Neurochemical Research

Volumn 34, Issue 8, 2009, Pages 1427-1432

  Husain, Maroof ^a,b   Shukla, Rakesh ^c   Dikshit, Madhu ^d   Maheshwari, Pradeep K ^e   Nag, Devika ^c   Srimal, Rikhab C ^a   Seth, Prahlad K ^a   Khanna, Vinay K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

^e S N MEDICAL COLLEGE   (India)

Author keywords

Idiopathic Parkinson 's disease; Monoamine oxidase B; Platelet

Indexed keywords

AMANTADINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIOXIDANT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE DURATION; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; INDIAN; MALE; MONOTHERAPY; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE;

ADULT; AGED; AMANTADINE; ANTIPARKINSON AGENTS; BLOOD PLATELETS; DISEASE PROGRESSION; FEMALE; HUMANS; INDIA; LEVODOPA; MALE; MIDDLE AGED; MONOAMINE OXIDASE; PARKINSON DISEASE; YOUNG ADULT;

EID: 67349144427     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-9929-4     Document Type: Article

References (68)

1. S Moghal AH Rajput C D' Arey R Rajput 1994 Prevalence of movement disorders in elderly community residents Neuroepidemiology 13 175 178 10.1159/000110376 (Pubitemid 24197317)
2. Ratner MH, Feldman RG (2005) Environmental toxins and Parkinson's disease. In: Ebadi M, Pfeiffer RF (eds) Parkinson's disease. CRC Press, Florida, pp 51-62
3. EP Bharucha NE Bharucha 1993 Epidemiological study of Parkinson's disease in Parsis in India Adv Neurol 60 352 354
4. E Tandberg JP Larsen EG Nessler T Riise JA Aarli 1995 The epidemiology of Parkinson's disease in the country of Rogaland Norway Mov Disord 10 541 549 10.1002/mds.870100503
5. RL Sutcliffe JR Meara 1995 Parkinson's disease epidemiology in the Northampton district, England, 1992 Acta Neurol Scand 92 443 450
6. ZX Zhang GC Roman 1993 Worldwide occurrence of Parkinson's disease: an updated review Neuroepidemiology 12 195 208 10.1159/000110318 (Pubitemid 23353338)
7. Korell M, Tanner CM (2005) Epidemiology of Parkinson's disease: an overview. In: Ebadi M, Pfeiffer RF (eds) Parkinson's disease. CRC Press, Florida, pp 39-50
8. Kumar A, Huang Z, Calne DB (2005) Parkinson's disease: where are we? In: Ebadi M, Pfeiffer RF (eds) Parkinson's disease. CRC Press, Florida, pp 27-38
9. JM Gorell CC Johnson BA Rybicki EL Peterson GX Kortsha GG Grown 1997 Occupational exposures to metals as risk factors for Parkinson's disease Neurology 48 3 650 658 (Pubitemid 27120101)
10. JM Gorell CC Johnson BA Rybicki EL Peterson RJ Richardson 1998 The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 5 1346 1350 (Pubitemid 28240350)
11. BCL Lai SA Marion K Teschke JKC Tsui 2002 Occupational and environmental risk factors for Parkinson's disease Parkinsonism Relat Disord 8 297 309 10.1016/S1353-8020(01)00054-2
12. M Zorzon L Capus A Pellegrino G Cazzato R Zivadinov 2002 Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy Acta Neurol Scand 105 2 77 82 10.1034/j.1600-0404.2002.1o040.x
13. A Menegon PG Board AC Blackburn GD Mellick DG Le Couteukr 1998 Parkinson's disease, pesticides and glutathione transferase polymorphisms Lancet 352 9137 1344 1346 10.1016/S0140-6736(98)03453-9
14. KM Semchuk EJ Love 1995 Effects of agricultural work and other proxy-derived case-control data on Parkinson's disease risk estimates Am J Epidemiol 141 8 747 754
15. A Priyadarshi SA Khuder EA Schaub S Shrivastava 2000 A meta-analysis of Parkinson's disease and exposure to pesticides Neurotoxicology 21 4 435 440 (Pubitemid 30740086)
16. R Betarbet TB Sherer G Mac Kenzie M Garcia-Osuna AV Panov JT Greenamyre 2000 Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 12 1301 1306 10.1038/81834
17. AE Lange AM Lozano 1998 Parkinson's disease: first of two parts N Engl J Med 339 1044 1053 10.1056/NEJM199810083391506
18. Cohen G (1999) Oxidative stress and Parkinson's disease. In: Gilbert DC, Colton CA (eds) Reactive oxygen species in biological systems. Kluwer Academic/Plenum Publishers, New York
19. JT Coyle P Puttfarken 1993 Oxidative stress, glutamate and neurodegenerative disorders Science 262 689 694 10.1126/science.7901908
20. CW Olanow 1993 A radical hypothesis for neurodegeneration Trends Neurosci 16 439 444 10.1016/0166-2236(93)90070-3
21. P Jenner CW Olanow 1996 Oxidative stress and pathogenesis of Parkinson's disease Neurology 47 6, Suppl 3 S161 S170
22. A Samii JG Nutt BR Ransom 2004 Parkinson's disease Lancet 363 1783 1793 10.1016/S0140-6736(04)16305-8
23. DJ Moore AB West VL Dawson TM Dawson 2005 Molecular pathophysiology of Parkinson's disease Annu Rev Neurosci 28 57 87 10.1146/annurev.neuro.28.061604. 135718
24. VK Khanna PK Maheshwari D Nag PK Seth 1990 Usefulness of platelet neurotransmitter receptors in Parkinson's disease Eur J Pharmacol 183 531 532 10.1016/0014-2999(90)93436-T (Pubitemid 20243146)
25. W Weyler YP Hsu XO Breakfield 1990 Biochemistry and genetics of monoamine oxidase Pharmacol Ther 47 391 417 10.1016/0163-7258(90)90064-9 (Pubitemid 20309559)
26. LM Kochersperger EL Parker M Siciano GJ Darlington RM Denly 1986 Assignment of genes for human monoamine oxidase A and B to the X chromosomes J Neurosci Res 16 601 616 10.1002/jnr.490160403 (Pubitemid 17218440)
27. JJ Chen DM Swope K Dashtipour 2007 Comprehensive review of rasagiline, a second generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease Clin Ther 29 1825 1846 10.1016/j.clinthera.2007.09.021
28. NL Pedersen L Oreland C Reynolds GE McClearn 1993 Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together Psychiatry Res 46 239 251 10.1016/0165-1781(93)90092-U
29. J Rice P McGuffin LR Goldin EG Shaskan ES Gershon 1984 Platelet monoamine oxidase (MAO) activity: evidence for a single major locus Am J Hum Genet 36 36 43 (Pubitemid 14192765)
30. GD Mellick DD Buchanan SJ McCann KM James AG Johnson DR Davis N Liyou D Chan DG Le Couteur 1999 Variations in the monoamine oxidase B (MAO B) gene are associated with Parkinson's disease Mov Disord 14 2 219 224 10.1002/1531- 8257(199903)14:2<219::AID-MDS1003>3.0.CO;2-9
31. Kinemuchi H, Arai Y, Fowler CJ (1993) A role for monoamineoxidase in the development of Parkinson's disease. In: Yasuhara H (ed) Monoamine oxidase and Parkinson's disease. Academic Press, London, pp 127-135
32. G Steventon C Humfrey S Sturman RH Waring AC Williams 1990 Monoamine oxidase-B and Parkinson's disease Lancet 20 180 10.1016/0140-6736(90)90063-B
33. P Bongioanni C Mondino B Boccardi M Borgna 1996 Monoamine molecular activity in platelets of parkinsonian and demented patients Neurodegeneration 5 351 357 10.1006/neur.1996.0047
34. U Bonuccelli P Piccini P Del Dotto GM Pacifici GU Corsini A Muratorio 1990 Platelet monoamine oxidase B activity in Parkinsonian patients J Neurol Neurosurg Psychiatry 53 854 855 10.1136/jnnp.53.10.854 (Pubitemid 20351048)
35. W Danielczyk M Streifler C Konradic P Reiderer G Moll 1988 Platelet MAO-B activity and the psychopathology of Parkinson's disease, seniile dementia and multi-infarct dementia Acta Psychiatr Scand 78 730 736 10.1111/j.1600-0447.1988. tb06412.x (Pubitemid 19027343)
36. C Humfrey G Steventon S Sturman RH Waring B Griffiths AC Williams 1990 Monoamine oxidase substrate in Parkinson's disease Biochem Pharmacol 41 2562 2564 10.1016/0006-2952(90)90101-P
37. W Kuhn T Muller A Gerstner R Winkel ME Goetz 1998 Platelet monoamine oxidase B activity in de novo and L-dopa treated Parkinsonian patients and controls Can J Neurol Sci 25 249 251 (Pubitemid 28368802)
38. H Checkoway FM Farin P Costa-Mallen SC Kirchner LG Costa 1998 Genetic polymorphism in Parkinson's disease Neurotoxicology 19 635 644
39. MA Herman H Checkoway R O'Brien P Costa-Mallen I De Vivo GA Colditz DJ Hunter KT Kelsey A Ascherio 2002 MAO-B intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD Neurology 58 1381 1387 (Pubitemid 34507165)
40. SN Kelada P Costa-Mallen LG Costa T Smith-Weller GM Pranklin PD Swanson WT Longstreth H Checkoway 2002 Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease Neurotoxicology 23 515 519 10.1016/S0161-813X(02)00061-X
41. EK Tan Y Chai SY Lum H Shen C Tan ML Teoh Y Yih MC Wong Y Zhao 2003 Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: a study in an Asian population Am J Med Genet 120B 58 62 10.1002/ajmg.b.20035 (Pubitemid 37059380)
42. A Parsian B Racette ZH Shang M Rundle JS Perlmutter 2004 Association of variations in monoamine oxidase A and B with Parkinson's disease subgroups Genomics 83 454 460 10.1016/j.ygeno.2003.09.002
43. DB Calne BJ Snow C Lee 1992 Criteria for diagnosing Parkinson's disease Ann Neurol 32 S125 S127 10.1002/ana.410320721
44. MM Hoehn MD Yahr 1967 Parkinsonism, onset, progression and mortality Neurology 17 427 442 (Pubitemid 33596369)
45. O Suzuki H Seno T Kumazawa 1988 In vitro inhibition of human platelet monoamine oxidase by phenothiazine derivatives Life Sci 42 2131 2136 10.1016/0024-3205(88)90127-0
46. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 265 275
47. DL Murphy RJ Wyatt 1972 Reduced monoamine oxidase activity in blood platelet from schizophrenia patients Nature 238 225 226 10.1038/238225a0
48. MM Caramona MD Cotrim CF Ribeiro T Macedo 1990 Monoamine oxidase in blood platelets of migraine patients J Neural Transm Suppl 32 161 164
49. V Glover R Peatfield R Zammit-Pace J Littlewood M Gawel FC Rose 1981 Platelet monoamine oxidase activity and headache J Neurol Neurosurg Psychiatry 44 786 790 10.1136/jnnp.44.9.786
50. J Littlewood V Glover M Sandler R Petty R Peatfield FC Rose 1984 Migraine and cluster headache: links between platelet monoamine oxidase activity, smoking and personality Headache 24 30 34 10.1111/j.1526-4610.1984.hed2401030.x (Pubitemid 14184243)
51. M Diaz-Marsa JL Carrasco E Hollander J Cesar J Saiz-Ruiz 2000 Decreased platelet monoamine oxidase activity in female anorexia nervosa Acta Psychiatr Scand 101 226 230 10.1046/j.0902-4441.2000.ap90062.x (Pubitemid 30108373)
52. ME Gotz P Fischer W Gsell P Riederer M Streifler M Simanyi F Muller W Danielczyk 1998 Platelet monoamine oxidase-B activity in dementia-a 4 year follow up Dement Geriatr Cogn Disord 9 74 77 10.1159/000017026
53. N Andreu C Damase-Michel JM Senard O Rascol JL Montastru 1997 A dose-ranging study of selegiline in patients with Parkinson's disease: effect on platelet monoamine oxidase activity Mov Disord 12 293 296 10.1002/mds.870120305
54. G Zhou Y Miura H Shoji S Yamada T Matsuishi 2001 Platelet monoamine oxidase B and plasma beta phenylethylamine in Parkinson's disease J Neurol Neurosurg Psychiatry 70 229 231 10.1136/jnnp.70.2.229
55. Bertoni J, Elmer L (2005) The role of MAO-B inhibitors in the treatment of Parkinson's disease. In: Ebadi M, Pfeiffer RF (eds) Parkinson's disease. CRC Press, Florida, pp 691-704
56. AE Lang A Lees 2002 MAO-B inhibitors for the treatment of Parkinson's disease Mov Disord 17 S4 S38 S44 10.1002/mds.5559
57. J Jarman V Glover M Sandler M Turjanski G Stern 1993 Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation J Neural Transm Park Dis Dement Sect 5 1 4 10.1007/BF02260909
58. Jankovic JJ (2002) Therapeutic strategies in Parkinson's disease. In: Jankovic JJ, Tolosa E (eds) Parkinson's disease and movement disorders. Lippincott, Philadelphia
59. LA Peterson AV Juorio MD Berry MY Zhu 1991 Inhibition of monoamine oxidase-B by (-) deprenyl potentiates neuronal response to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum J Pharmacol Exp Ther 258 1019 1024
60. MD Berry E Scarr MY Zhu LA Peterson AV Jourio 1994 The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurons response to dopamine Br J Pharmacol 113 1159 1166 (Pubitemid 24364393)
61. DH Lee M Mendoza MT Dyorozniak E Chung MH Van Woert MD Yahr 1989 Platelet monoamine oxidase in Parkinson patients: effect of l-deprenyl therapy J Neural Transm 1 189 194 10.1007/BF02248668 (Pubitemid 19250132)
62. JS Fowler ND Volkow GJ Wong N Pappas J Logan R MacGregor D Alexoff C Shea D Schlyer AP Wolf D Warner I Zezulkova R Cilento 1996 Inhibition of monoamine oxidase in the brains of smokers Nature 379 733 736 10.1038/379733a0
63. GM Franklin H Checkoway P Costa-Mallen PD Swanson T Smith-Weller DG Levy LG Costa 1997 The "protective" effect of smoking in Parkinson's disease is modified by an MAO-B polymorphism Neurology 48 A334 A335 (Abstract)
64. A Veral G Alper G Mentes B Ersoz 1997 Age and sex related alterations in serum and platelet monoamine oxidase Eur J Clin Chem Clin Biochem 35 265 268 (Pubitemid 27229347)
65. JH Kurth MC Kurth SE Poduslo JD Schwankhaus 1993 Association of monoamine oxidase-B allele with Parkinson's disease Ann Neurol 33 368 372 10.1002/ana.410330406 (Pubitemid 23103968)
66. P Costa H Checkoway D Levy T Smith-Weller GM Franklin PD Swanson LG Costa 1997 Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease Am J Med Genet 74 154 156 10.1002/(SICI)1096- 8628(19970418)74:2<154::AID-AJMG7>3.0.CO;2-U
67. M Bialecka G Klodowska-Duda K Honczarenko B Gawronska-Szklarz G Opala K Safrano M Drozdzik 2007 Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), n-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease Parkinsonism Relat Disord 13 4 224 229 10.1016/j.parkreldis.2006.10.006
68. H Garpenstrand J Ekblom K Forslund G Rylander L Oreland 2000 Platelet monoamine oxidase activity is related to MAO-B intron 13 genotype J Neural Transm 107 523 530 10.1007/s007020070075 (Pubitemid 30251736)